Alys Pharmaceuticals

Developer of therapeutics for immuno-dermatological conditions

placeBoston, Massachusetts, United States calendar_todayFounded 2024 language alyspharma.com

Registered entities

Social engagement

Social engagement: 2.6K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record; lead investors include Medicxi.

Investor typeCountShare
Venture capital1100%

Recent activity

17 Nov 2025
Milestone
regulatory
30 Oct 2025
Milestone
regulatory
3 Oct 2025
Milestone
regulatory
Coming soon